CB Insights December 1, 2020
Kedar Karkare

Genomics is enabling more individualized treatment by providing insight into which genes contribute to various medical conditions.

For example, scientists are currently using genomics to understand how Covid-19 spreads and affects the immune system. This information could help with vaccine development.

A single human genome sequence generates between 300GB to 1TB of data. Technological improvements have driven down the costs of sequencing — a historically expensive process — and caused an explosion in genomic data over the past decade. This has created multiple opportunities for artificial intelligence in the space.

Companies are working to commercialize AI-based genomics solutions to develop better pharmaceuticals, power more accurate disease diagnosis, and help physicians identify the most effective treatments.

Below we analyze 3...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma / Biotech, Precision Medicine, Technology
Cofactor AI Nabs $4M to Combat Hospital Claim Denials with AI
Set Your Team Up to Collaborate with AI Successfully
What’s So Great About Nvidia Blackwell?
Mayo develops new AI tools
Medtronic, Tempus testing AI to find potential TAVR patients

Share This Article